~~<i id='FCB8F4B081'><strike id='FCB8F4B081'><tt id='FCB8F4B081'><pre id='FCB8F4B081'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

explore

author：comprehensive 2025-09-14 08:29:51 - browse：258

An illustration of red blood cells — Adobe

As a boy growing up with hemophilia A, Noah Frederick reserved the end of his annual checkups to talk about new technologies. His doctor walked through various experimental approaches for the bleeding disorder and, invariably, gene therapy. It was coming, he always said, in your lifetime.

Last year, it finally arrived. But Frederick, now a 23-year-old software engineer, isn’t sure he’ll get it. He wants to be part of the sci-fi future gene therapy has always represented, but a recent doctor’s visit left him uncertain.

“I’m on the fence,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Wikipedia

leisure time

explore

knowledge

hotspot

focus

INAFASSBENDER/AFPviaGettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup tog

WSS

New study raises questions about niacin and heart health

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Maisha Meds is a PBM, but don't call it that

High breast density mammograms need follow

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Printout prescription drug information shouldn’t go digital

entertainment

explore

Wikipedia

Heart attack and stroke risk calculators need revising

Immunocompromised patients offer clues on chronic Covid

Hepatitis C has a cure — but many Americans still lack access to it

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Drug repurposing or repositioning? The language matters

The inclusion problem at the heart of rehabilitation research

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Immunocompromised patients offer clues on chronic Covid

How to save PrEP access — and even expand it

Ukraine seeks to reclaim its role as a hub for clinical trials

leisure time

FDA warns medical device makers about rise in fabricated data

The inclusion problem at the heart of rehabilitation research

Pumping milk in bathrooms at health conferences is common

Opioid cravings were reduced by anti

Future doctors need a strong humanities education

CVS is on a mission to consolidate health care. Will it work?

explore

knowledge

hotspot

focus